Vitamin D Status in Children With High-risk Neuroblastoma.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
received:
03
05
2023
accepted:
11
09
2023
medline:
30
10
2023
pubmed:
2
10
2023
entrez:
2
10
2023
Statut:
ppublish
Résumé
Vitamin D deficiency has become a matter of concern in pediatric cancer patients. A relationship between neuroblastoma and Vitamin D signaling pathways has been revealed with interest in the antiproliferative and antiinvasive properties of vitamin D. Our aim is to describe the prevalence of Vitamin D deficiency among children with high-risk neuroblastoma (HR-NB) and to explore its association with disease status. In all, 182 patients with HR-NB were managed at our center from 2017 to 2021. Serum 25(OH)D levels were tested at the first blood analysis performed and correlated with clinical data and disease status. One hundred forty-eight (81.4%) had low 25(OH)D levels (48.4% categorized as deficiency (25(OH)D below 20 ng/mL) and 33.0% as insufficiency (25(OH)D 20 to 30 ng/mL). Median Vitamin D level was 20.2 ng/mL. Vitamin D levels were not associated with race or sex. Although malnourished patients had lower median 25(OH)D levels(11.1 ng/mL), no statistical association was observed with Vitamin D deficiency. There was no association between Vitamin D levels and disease status. An inverse correlation was found between age and vitamin D levels ( P =0.0040). A concerning high prevalence of low Vitamin D levels affects more than two-thirds of patients with HR-NB in our cohort, regardless of the disease status at the time of evaluation. Older children are at a higher risk for deficient levels of vitamin D.
Sections du résumé
BACKGROUND
Vitamin D deficiency has become a matter of concern in pediatric cancer patients. A relationship between neuroblastoma and Vitamin D signaling pathways has been revealed with interest in the antiproliferative and antiinvasive properties of vitamin D. Our aim is to describe the prevalence of Vitamin D deficiency among children with high-risk neuroblastoma (HR-NB) and to explore its association with disease status.
MATERIALS AND METHODS
In all, 182 patients with HR-NB were managed at our center from 2017 to 2021. Serum 25(OH)D levels were tested at the first blood analysis performed and correlated with clinical data and disease status.
RESULTS
One hundred forty-eight (81.4%) had low 25(OH)D levels (48.4% categorized as deficiency (25(OH)D below 20 ng/mL) and 33.0% as insufficiency (25(OH)D 20 to 30 ng/mL). Median Vitamin D level was 20.2 ng/mL. Vitamin D levels were not associated with race or sex. Although malnourished patients had lower median 25(OH)D levels(11.1 ng/mL), no statistical association was observed with Vitamin D deficiency. There was no association between Vitamin D levels and disease status. An inverse correlation was found between age and vitamin D levels ( P =0.0040).
CONCLUSION
A concerning high prevalence of low Vitamin D levels affects more than two-thirds of patients with HR-NB in our cohort, regardless of the disease status at the time of evaluation. Older children are at a higher risk for deficient levels of vitamin D.
Identifiants
pubmed: 37779236
doi: 10.1097/MPH.0000000000002762
pii: 00043426-202311000-00010
doi:
Substances chimiques
Vitamin D
1406-16-2
Vitamins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e953-e958Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Gordon CM, Feldman H, Sinclair L, et al. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arc Pediatr Adolesc Med. 2008;162:505–512.
Kumar J, Muntner P, Kaskel FJ, et al. Prevalence and associations of 25-Hydroxyvitamin D deficiency in US Children: NHANES 2001-2004. Pediatrics. 2009;124:e362–e370.
Revuelta Iniesta R, Rush R, Paciarotti I, et al. Systematic review and meta-analysis: prevalence and possible causes of vitamin D deficiency and insufficiency in pediatric cancer patients. Clin Nutr. 2016;35:95–108.
Fullmer M, Su A, Bachrach S, et al. Newly diagnosed children with cancer have lower 25-Vitamin D levels than their cancer-free peers: A Comparison across Age, Race, and Sex. Cancers. 2022;14:2378.
Gebauer J, Higham C, Langer T, et al. Long-term endocrine and metabolic consequences of cancer treatment: a systematic review. Endocr Rev. 2019;40:711–767.
Iruretagoyena M, Hirigoyen D, Naves R, et al. Immune response modulation by vitamin D: role in systemic lupus erythematosus. Front Immunol. 2015;6:513.
Christakos S, Ajibade DV, Dhawan P, et al. Vitamin D: Metabolism. Endocrinol Metab Clin North Am. 2010;39:243–253.
Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50:20.
Antonucci R, Locci C, Clemente MG, et al. Vitamin D deficiency in childhood: old lessons and current challenges. J Pediatr Endocrinol Metab. 2018;31:247–260.
Feldman D, Krishnan A, Swami S, et al. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14:342–357.
Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res. 1941;1:191–195.
Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9:227–231.
Garland CF, Gorham ED, Mohr SB, et al. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19:468–483.
Mondul AM, Weinstein SJ, Layne TM, et al. Vitamin D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev. 2017;39:28–48.
Gumireddy K, Ikegaki N, Phillips PC, et al. Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferayion of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway. Biochem Pharmacol. 2003;65:1943–1955.
Matthay KK, Maris JM, Schleiermacher G, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078.
Celli A, Treves C, Stio M. Vitamin D receptor in SH-SY5Y human neuroblastoma cells and effect of 1,25-dihydroxyvitamin D3 on cellular proliferation. Neurochem Int. 1999;34:117–124.
Van Ginkel PR, Yang W, Marcet MM, et al. 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol. 2007;85:255–262.
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
Harris PA, Taylor R, Minor BL, et al. REDCap Consortium, The REDCap consortium: Building an international community of software partners. J Biomed Inform. 2019;95:103208.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930.
Park JR, Bagatell R, Cohn SL, et al. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From The National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2017;35:2580–2587.
R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2022). https://www.R-project.org/
Choudhary A, Chou J, Heller G, et al. Prevalence of vitamin D insufficiency in survivors of childhood cancer. Pediatr Blood Cancer. 2013;60:1237–1239.
Weng FL, Shults J, Leonard MB, et al. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr. 2007;86:150–158.
Fuleihan GEH, Nabulsi M, Choucair M, et al. Hypovitaminosis D in healthy schoolchildren. Pediatrics. 2001;107:E53.
Aristizabal P, Sherer M, Perdomo BP, et al. Sociodemographic and clinical characteristics associated with vitamin D status in newly diagnosed pediatric cancer patients. Pediatr Hematol Oncol. 2020;37:314–325.
Helou M, Ning Y, Yang S, et al. Vitamin d deficiency in children with cancer. J Pediatr Hematol Oncol. 2014;36:212–217.
Sinha A, Avery P, Turner S, et al. Vitamin D status in paediatric patients with cancer. Pediatr Blood Cancer. 2011;57:594–598.
Genc DB, Vural S, Yagar G. The incidence of and factors associated with vitamin D deficiency in newly diagnosed children with cancer. Nutr Cancer. 2016;68:756–761.
Rosen GP, Beebe KL, Shaibi GQ. Vitamin D levels differ by cancer diagnosis and decline over time in survivors of childhood cancer. Pediatr Blood Cancer. 2013;60:949–952.
Jackmann N, Gustafsson J, Harila-Saari A, et al. Prevalence of and factors influencing vitamin D deficiency in paediatric patients diagnosed with cancer at northern latitudes. Acta Paediatr. 2021;110:2252–2258.
Gutiérrez OM, Farwell WR, Kermah D, et al. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011;22:1745–1753.
Wright NC, Chen L, Niu J, et al. Defining physiologically “normal” Vitamin D in African Americans. Osteoporos Int. 2012;23:2283–2291.
Zhang W, Stoecklin E, Eggersdorfer M. A glimpse of vitamin D status in Mainland China. Nutrition. 2013;29:953–957.
Diakatou V, Vassilakou T. Nutritional status of pediatric cnacer patients at diagnosis and correlations with treatment, clinical ouitcome and the long.term growth and health of survivors. Children (Basel). 2020;7:218.
Barr RD, Gomez-Almaguer D, Jaime-Perez JC, et al. Importance of nutrition in the treatment of leukemia in children and adolescents. Arch Med Res. 2016;47:585–592.
Brinksma A, Huizinga G, Sulkers E, et al. Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol. 2012;83:249–275.
Simmons JH, Chow EJ, Koehler E, et al. Significant 25-hydroxyvitamin D deficiency in child and adolescent survivors of acute lymphoblastic leukemia: treatment with chemotherapy compared with allogeneic stem cell transplant. Pediatr Blood Cancer. 2011;56:1114–1119.
Jackmann N, Makitie O, Harila-Saari A, et al. Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood Cancer. 2020;67:e28163.
Revuelta Iniesta R, Paciarotti I, Davidson I, et al. 5-Hydroxyvitamin D concentration in paediatric cancer patients from Scotland: a prospective cohort study. Br J Nutr. 2016;116:1926–1934.
Atkinson SA. Vitamin D status and bone biomarkers in childhood cancer. Pediatr Blood Cancer. 2008;50(2 Suppl):479–482.
Juhász O, Jakab Z, Szabó A, et al. Examining the Vitamin D Status of Children with solid tumors. J Am Coll Nutr. 2020;39:128–134.
Khamissa RAG, Fourie J, Motswaledi MH, et al. The Biological activities of vitamin D and its receptor in relation to calcium and bone homeostasis, cancer, immune and cardiovascular systems, skin biology, and oral health. Biomed Res Int. 2018;2018:9276380.
Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634–1647.
Juhász O, Jákob N, Rajnai H, et al. Immunohistochemical detection of the presence of vitamin D receptor in childhood solid tumors. Cancers. 2022;14:3295.
Bini F, Frati A, Garcia-Gil M, et al. New signaling pathway involved in the anti-proliferative action of vitamin D3 and its analogues in human neuroblastoma cells. A role for ceramide kinase. Neuropharmacology. 2012;63:524–537.
Ladumor Y, Seong BKA, Hallet R, et al. Vitamin D receptor activation attenuates hippo pathway effectors and cell survival in metastatic neuroblastoma. Mol Cancer Res. 2022;20:895–908.